Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Literature
1.
Hirakawa T, Kato J, Okumura Y, Hori K, Takahashi S, Suzuki H, et al. Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT). J Gastroenterol. 2012;47:127–35.PubMedCrossRef
2.
Lee JC, Hartnett GF, Hughes BG, Ravi Kumar AS. The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT. Nucl Med Commun. 2009;30:333–7.PubMedCrossRef
3.
Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61–77 (quiz 150–1).
Metadata
Title
Reply to the letter by A. S. Ravi Kumar et al. regarding “Detectability of colorectal neoplasia with FDG-PET/CT”
Authors
Tomoko Hirakawa
Jun Kato
Publication date
01-06-2012
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 6/2012
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0594-z

Other articles of this Issue 6/2012

Journal of Gastroenterology 6/2012 Go to the issue

Original Article—Alimentary Tract

Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan

Original Article—Alimentary Tract

Partial normalization of pubertal timing in female mice with DSS colitis treated with anti-TNF-α antibody

Original Article—Liver, Pancreas, and Biliary Tract

Algorithm to determine the outcome of patients with acute liver failure: a data-mining analysis using decision trees

Original Article—Liver, Pancreas, and Biliary Tract

Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy

Original Article—Liver, Pancreas, and Biliary Tract

Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

Original Article—Alimentary Tract

Predictive factors of local recurrence after endoscopic piecemeal mucosal resection
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits